Candas B - Search Results

1

Major impact of hormonal therapy in localized prostate cancer--death can already be an exception.

Labrie F, Cusan L, Gomez J, Luu-The V, Candas B, Bélanger A, Labrie C. Labrie F, et al. Among authors: candas b. J Steroid Biochem Mol Biol. 2004 Dec;92(5):327-44. doi: 10.1016/j.jsbmb.2004.10.011. Epub 2004 Dec 21. J Steroid Biochem Mol Biol. 2004. PMID: 15698538 Review.

2

Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?

Labrie F, Candas B, Gomez JL, Cusan L. Labrie F, et al. Among authors: candas b. Urology. 2002 Jul;60(1):115-9. doi: 10.1016/s0090-4295(02)01639-4. Urology. 2002. PMID: 12100935 Clinical Trial.

3

Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey.

Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F. Leblanc M, et al. Among authors: candas b. J Steroid Biochem Mol Biol. 2002 Jun;81(2):159-64. doi: 10.1016/s0960-0760(02)00059-6. J Steroid Biochem Mol Biol. 2002. PMID: 12137806

4

[From the gene to the clinic: prostate cancer death can now be an exception?].

Labrie F, Cusan L, Gomez JL, Candas B, Bélanger A, Luu-The V, Labrie C, Simard J. Labrie F, et al. Among authors: candas b. Med Sci (Paris). 2003 Oct;19(10):910-9. doi: 10.1051/medsci/20031910910. Med Sci (Paris). 2003. PMID: 14612999 Free article. Review. French.

5

Gonadotropin-releasing hormone agonists in the treatment of prostate cancer.

Labrie F, Bélanger A, Luu-The V, Labrie C, Simard J, Cusan L, Gomez J, Candas B. Labrie F, et al. Among authors: candas b. Endocr Rev. 2005 May;26(3):361-79. doi: 10.1210/er.2004-0017. Epub 2005 May 2. Endocr Rev. 2005. PMID: 15867098 Review.

6

Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women.

Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J. Labrie F, et al. Among authors: candas b. J Steroid Biochem Mol Biol. 2006 Jun;99(4-5):182-8. doi: 10.1016/j.jsbmb.2006.02.004. Epub 2006 Apr 18. J Steroid Biochem Mol Biol. 2006. PMID: 16621522

7

Metabolism of DHEA in postmenopausal women following percutaneous administration.

Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J. Labrie F, et al. Among authors: candas b. J Steroid Biochem Mol Biol. 2007 Feb;103(2):178-88. doi: 10.1016/j.jsbmb.2006.09.034. Epub 2006 Nov 3. J Steroid Biochem Mol Biol. 2007. PMID: 17084625 Clinical Trial.

8

Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality.

Labrie F, Cusan L, Gomez JL, Diamond P, Candas B. Labrie F, et al. Among authors: candas b. J Clin Endocrinol Metab. 1995 Jul;80(7):2002-13. doi: 10.1210/jcem.80.7.7541800. J Clin Endocrinol Metab. 1995. PMID: 7541800 Review.

9

Neoadjuvant hormonal therapy: the Canadian experience.

Labrie F, Cusan L, Gomez JL, Diamond P, Suburu R, Lemay M, Tetu B, Fradet Y, Bélanger A, Candas B. Labrie F, et al. Among authors: candas b. Urology. 1997 Mar;49(3A Suppl):56-64. doi: 10.1016/s0090-4295(97)00170-2. Urology. 1997. PMID: 9123738 Clinical Trial.

10

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.

Labrie F, Candas B, Dupont A, Cusan L, Gomez JL, Suburu RE, Diamond P, Lévesque J, Belanger A. Labrie F, et al. Among authors: candas b. Prostate. 1999 Feb 1;38(2):83-91. doi: 10.1002/(sici)1097-0045(19990201)38:2<83::aid-pros1>3.0.co;2-b. Prostate. 1999. PMID: 9973093 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters